These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16394599)

  • 1. Influence of interferon therapy on signal-averaged and ambulatory electrocardiograms in patients with chronic active hepatitis.
    Hiramatsu S; Maruyama T; Ito H; Shimoda S; Kaji Y; Harada M
    Int Heart J; 2005 Nov; 46(6):1033-40. PubMed ID: 16394599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of signal-averaging electrocardiographic systems using device specific criteria in 104 normal subjects.
    Moreno FL; Karagounis LA; Villanueva T; Horn SD; Anderson JL
    Pacing Clin Electrophysiol; 1994 Nov; 17(11 Pt 2):2178-82. PubMed ID: 7845839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel signal-averaged electrocardiogram and an ambulatory-based signal-averaged electrocardiogram show strong correlations with conventional signal-averaged electrocardiogram in healthy subjects: A validation study.
    Hashimoto K; Takase B; Nagashima M; Kasamaki Y; Shimabukuro H; Soma M; Nakayama T
    J Electrocardiol; 2018; 51(6):1145-1152. PubMed ID: 30497747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of mexiletine, propafenone and flecainide on signal-averaged electrocardiogram.
    Lombardi F; Finocchiaro ML; Dalla Vecchia L; Rech R; Castelli A; Pastine J; Cappiello E
    Eur Heart J; 1992 Apr; 13(4):517-25. PubMed ID: 1600992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal averaging of pre- and post-extrasystolic beats in patients with ventricular arrhythmias.
    Lombardi F; Finocchiaro ML; Dalla Vecchia L; Cappiello E; Vianello R; Baselli G; Cerutti S
    Eur Heart J; 1991 Apr; 12(4):481-7. PubMed ID: 1712304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of high-risk Brugada syndrome patients by combined analysis of late potential and T-wave amplitude variability on ambulatory electrocardiograms.
    Yoshioka K; Amino M; Zareba W; Shima M; Matsuzaki A; Fujii T; Kanda S; Deguchi Y; Kobayashi Y; Ikari Y; Kodama I; Tanabe T
    Circ J; 2013; 77(3):610-8. PubMed ID: 23439592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Later potentials on signal-averaged electrocardiograms in children after right ventriculotomy.
    Rovamo L; Mäkijärvi M; Pesonen E; Wallgren EI; Toivonen L
    Pediatr Cardiol; 1995; 16(3):114-9. PubMed ID: 7617504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of the signal-averaged QRS in patients with arrhythmogenic right ventricular dysplasia.
    Blomström-Lundqvist C; Hirsch I; Olsson SB; Edvardsson N
    Eur Heart J; 1988 Mar; 9(3):301-12. PubMed ID: 3383870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation for micropotential analysis by signal-averaged ECG using Holter monitoring].
    Yakubo S; Ozawa Y; Komaki K
    Nihon Rinsho; 1995 Feb; 53(2):321-7. PubMed ID: 7699853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of late potentials for 24 hours between Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy using a novel signal-averaging system based on Holter ECG.
    Abe A; Kobayashi K; Yuzawa H; Sato H; Fukunaga S; Fujino T; Okano Y; Yamazaki J; Miwa Y; Yoshino H; Ikeda T
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):789-95. PubMed ID: 22665699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of residual noise level on reproducibility of the signal-averaged ECG.
    Christiansen EH; Frost L; Mølgaard H; Nielsen TT; Pedersen AK
    J Electrocardiol; 1996 Jul; 29(3):235-41. PubMed ID: 8854334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up by repeated signal-averaged surface QRS in patients with the syndrome of arrhythmogenic right ventricular dysplasia.
    Blomström-Lundqvist C; Olsson SB; Edvardsson N
    Eur Heart J; 1989 Sep; 10 Suppl D():54-60. PubMed ID: 2806305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal-averaged ECG abnormalities in haemodialysis patients. Role of dialysis.
    Morales MA; Gremigni C; Dattolo P; Piacenti M; Cerrai T; Fazi A; Pelosi G; Vergassola R; Maggiore Q
    Nephrol Dial Transplant; 1998 Mar; 13(3):668-73. PubMed ID: 9550645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relations between ventricular late potentials and ventricular arrhythmias in mitral valve prolapse].
    Maraglino G; Sturaro M; Toniolo G; Accurso V; Pastore G; Palatini P
    G Ital Cardiol; 1994 Aug; 24(8):957-64. PubMed ID: 7958637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative analysis of ventricular late potentials (LP) in healthy subjects. Comparative study with Holter monitoring.
    Bassleer B; Ibrahim T; Friart J
    Acta Cardiol; 1992; 47(5):435-43. PubMed ID: 1441851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time course of moricizine's effect on signal-averaged and 12 lead electrocardiograms: insights into mechanism of action.
    Wechsler ME; Steinberg JS; Giardina EG
    J Am Coll Cardiol; 1991 Jun; 17(7):1626-33. PubMed ID: 1709654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of long term use of amiodarone hydrochloride on time and frequency domain parameters of signal averaged electrocardiogram in patients with ischemia heart disease].
    Telichowski A; Banasiak W; Bobak J; Telichowska H; Fuglewicz A; Wiech K; Pieróg M; Kałka D; Wysota J; Zebrowska M; Ponikowski P
    Pol Merkur Lekarski; 1997 Jun; 2(12):378-81. PubMed ID: 9424329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Late ventricular potentials in the post-infarct patient. A follow-up at 4 years].
    Verzoni A; Ravaglia R; Sangiorgio S; Tarricone D; Pozzoni L; Fiorentini C
    G Ital Cardiol; 1993 Jul; 23(7):661-71. PubMed ID: 8405832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal-averaged electrocardiogram shows a heart rate dependent diurnal variation in healthy subjects.
    Nakagawa M; Oda M; Iwao T; Ishida S; Yonemochi H; Fujino T; Saikawa T; Ito M
    Jpn Heart J; 1998 Mar; 39(2):147-52. PubMed ID: 9687823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of late potential in patients with Duchenne muscular dystrophy.
    Kubo M; Matsuoka S; Taguchi Y; Akita H; Kuroda Y
    Pediatr Cardiol; 1993 Oct; 14(4):214-9. PubMed ID: 8255794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.